Here's Why You Should Buy Kronos Worldwide Stock Right Now

Kronos Worldwide's TiO2 sales volumes increased 10% year over year in the first half of 2026 and average selling prices rose 4%, supporting management's expectation that full-year 2026 net sales will exceed 2025. Second-quarter gross margin expanded 500bps to 18%, segment profit rose to $41 million from $10.9 million, and EBITDA increased to $52.9 million from $22.2 million. Operating cash flow improved to positive $2 million in the first half from an $81.7 million outflow a year earlier, while inventory fell by $130.3 million to $498.3 million.

Analysis

KRO’s operating leverage is the key variable, not the headline volume recovery. TiO2 is a high-fixed-cost, cyclical market; incremental utilization and lower inventory can produce disproportionate EBITDA and working-capital improvement, but also make earnings highly sensitive to a reversal in European coatings and construction demand. The share-price rerating case requires evidence that realized prices hold after customer contracts reset, rather than merely reflecting trade-distuced supply dislocation and temporary destocking normalization.

Competitive effects favor Western producers with local capacity when import barriers and freight friction limit Chinese supply, including Chemours (CC) and Tronox (TROX). KRO may be the highest-beta beneficiary because its smaller scale and prior under-absorption create greater margin torque; conversely, CC and TROX offer more liquid vehicles for expressing a broader TiO2 tightening thesis. Downstream formulators and plastics processors—including AVNT—face raw-material pass-through risk, though diversified specialty mix should limit direct earnings sensitivity relative to commodity coatings producers.

The market is likely discounting cyclicality rather than giving full credit for the recovery. After a 36.6% one-year move, a long should be sized around confirmation catalysts over the next one to two quarters: sustained price realization, further inventory conversion to cash, and no deterioration in European industrial indicators. Thesis failure would be a sequential volume decline, gross margin retreat below the recent 18% level, or renewed Chinese export competition that forces price concessions; those outcomes would expose both earnings estimates and a thinly traded small-cap multiple.

Key Decisions for Investors

• Maintain a tactical long KRO only on pullbacks or following next-quarter confirmation of positive operating cash flow; target a 3-6 month holding period. Underwrite upside from margin normalization rather than further multiple expansion, and exit if gross margin falls below 16% or inventory rebuilds materially.
• Express the industry view through a basket: long KRO and TROX versus short AVNT only if TiO2 price indices and European coatings orders continue improving for 4-6 weeks. The pair isolates pigment tightness from broad materials beta; avoid initiation if AVNT demonstrates full contractual pass-through.
• Watch CC as a liquid read-through and potential relative-value short versus KRO if its TiO2 pricing commentary lags despite similar demand conditions. A divergence would indicate KRO’s gains are company-specific share capture rather than a durable industry upcycle.
• Do not treat IPI or IOSP as corroborating signals for KRO: their earnings drivers are fertilizer and specialty chemicals, respectively. Keep them separate from the TiO2 thesis despite the article’s bundled recommendations.